Affin Hwang Capital Research Highlights

Author: kltrader   |   Latest post: Tue, 19 Jan 2021, 5:59 PM


Bumi Armada - Margins Disappoint, But No Major Hiccups

Author:   |    Publish date:

  • 3Q20 core net profit of RM83m missed our expectation with deviation coming from weaker than expected FPO margin and consecutive quarter of associate losses
  • Operationally, FPO profit fell qoq on Kraken’s planned maintenance shutdown and OMS losses widening
  • Reiterate Buy with a slightly lower target price of RM0.36 (from RM0.39)

Margins disappoint

3Q20 revenue grew by 7% yoy to RM564m, attributable to a 27% improvement in OMS contribution and 4% increase in FPO revenue on the back of better FPSO Olombendo and Kraken performances. While 9M20 core net profit of RM301m (+33% yoy) made up 73% of our previous forecast, we deem it a slight miss with deviation coming from weaker-than-expected margins and consecutive quarters of associate losses. In terms of operating cash flow, 3Q saw a strong turnaround with 9M20 registering a 19% yoy improvement. This led to its overall net debt falling by 10% and lower net gearing of 2.58x (3Q20: 2.8x). Investors will find comfort that no large impairments are to be expected in 4Q20.

Kraken underwent maintenance shutdown in 3Q20

Sequentially, 3Q20 revenue fell 7% as FPO revenue fell by 10% owing to Armada Kraken’s planned maintenance shutdown. As a result, FPO operating profit fell 23% qoq. We gather that any planned maintenance exercise are often reimbursable through a provided allowance, but BAB has fully utilised the amount prior to this, and hence its FPO profit was affected. The 3 consecutive quarters of associates/JV losses was one of the main reasons for the earnings miss, due to recognition of DTL in 1Q, Sterling I extension study costs in 2Q and ONGC 98/2 related fee in the recent quarter.

Still underappreciated and undervalued – reaffirming BUY

We lower our 2020-22E EPS by 6-7% to factor in lower FPO margins and tweak associate contributions. Our new target price of RM0.36 (from RM0.39) offers potential upside of 36% from the current levels. In our view, BAB’s recent operational recovery is still underappreciated by investors. We expect to see a valuation re-rating once execution and earnings delivery becomes more consistent. Our target price implies 5.4x 2021E PER, representing a 33% discount to historical PER pre Kraken impairment. We also favour BAB given its resilient earnings under current low oil price environment, backed by its long-term FPSO contracts. Downside risks include weaker OSV fleet utilisation and termination of existing FPO contracts.

Source: Affin Hwang Research - 20 Nov 2020

Share this
Labels: ARMADA

Related Stocks

Chart Stock Name Last Change Volume 
ARMADA 0.345 -0.005 (1.43%) 17,942,400 

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Stock Screener using Technical and Fundamental criteria
MQ Affiliate
Join the MQ Affiliate Program today to earn rewards

321  714  537  547 

Top 10 Active Counters
 DNEX 0.255+0.03 
 HPPHB 0.74+0.03 
 LAMBO 0.030.00 
 AT 0.18+0.005 
 VSOLAR 0.04+0.005 
 PNEPCB 0.305-0.025 
 FINTEC 0.08+0.005 
 DNEX-WD 0.045+0.01 
 KSTAR 0.255-0.065 
 XOX 0.0950.00 


1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!